Market Overview

The Assistance Fund Launches New Program to Provide Financial Support to Individuals with Hereditary (ATTR) Amyloidosis

Share:

The Assistance Fund, an independent charitable patient assistance
foundation that helps patients and families facing high medical
out-of-pocket costs, launched a new financial assistance program to
provide support for individuals with Hereditary (ATTR) Amyloidosis. The
program covers out-of-pocket medical expenses, including medication
copays, health insurance premiums, deductibles, coinsurance and
incidental medical expenses for eligible individuals.

"It is with great excitement that we open this new financial assistance
program so that patients with Hereditary (ATTR) Amyloidosis can pursue
treatment without being burdened by undue financial stress," said The
Assistance Fund President and CEO Mark P. McGreevy.

"Hereditary Amyloidosis has a huge impact on families, in which
generations may be affected by the disease," said Isabelle Lousada,
President and CEO of the Amyloidosis Research Consortium. "As the
disease progresses, patients experience a considerable impact on their
quality of life and ability to work, as well as their social and
emotional well-being. New treatments that can slow progression and
minimize the effect of symptoms offer real hope to patients."

Hereditary (ATTR) Amyloidosis is a condition that affects organ tissue
structure and function when amyloid, an abnormal protein, is deposited
in multiple organs where it should not be, most often in tissues of the
heart, kidneys and nervous system.1 Symptoms can vary broadly
among patients and may include heart palpitations and abnormal heart
rhythms, a loss of sensation in the extremities, digestive issues,
swelling, and many other issues.2

"Finally, patients have hope for treating this disease," said Mary
O'Donnell, President and CEO of the Amyloidosis Foundation. "The
Assistance Fund's financial assistance program for Hereditary (ATTR)
Amyloidosis will provide extremely important support for patients who
may otherwise be unable to seek treatment due to high out-of-pocket
costs."

To learn more or determine eligibility for financial support from The
Assistance Fund, individuals should visit tafcares.org or
call 855-512-2801 to speak with a patient advocate.

A list of all the programs available at The Assistance Fund can be found
on the website tafcares.org.

About The Assistance Fund
The Assistance Fund is an
independent charitable patient assistance foundation that helps patients
and families facing high medical out-of-pocket costs by providing
financial assistance for their copayments, coinsurance, deductibles and
other health-related expenses. The Assistance Fund currently manages
more than 40 programs – each of which covers the FDA-approved
medications that treat a specific disease. Since its founding in 2009,
The Assistance Fund has helped more than 73,000 adults and children
access the medicines they need to stay healthy or manage a chronic
condition. To learn more about The Assistance Fund, or for information
on how to donate, please visit tafcares.org.

References

       

 

1.

"Hereditary amyloidosis." National Institutes of Health, National
Center for Advancing Translational Sciences, Genetic and Rare
Diseases Information Center. Retrieved from: https://rarediseases.info.nih.gov/diseases/6611/hereditary-amyloidosis.

 

2.

"Hereditary amyloidosis." Amyloidosis Foundation. Retrieved from: http://amyloidosis.org/facts/familial/#attr-amyloidosis.

View Comments and Join the Discussion!